See the DrugPatentWatch profile for Myoview
What is Myoview, and what is it used for?
Myoview is a brand name for technetium Tc 99m sestamibi, a radioactive imaging medicine used in nuclear cardiology to help doctors evaluate heart function and blood flow. It’s commonly used for myocardial perfusion imaging—tests that look for areas of reduced blood supply in conditions such as coronary artery disease.
Is Myoview still available, or has it been replaced?
Myoview’s availability has depended on manufacturer supply and the broader market for technetium Tc 99m imaging products. In the United States, competing versions may exist, but Myoview has historically been one of the well-known sestamibi options used for cardiac scans. If you’re asking because of access or shortages, availability can vary by location and time.
Why do clinicians choose sestamibi (Myoview) for heart scans?
Technetium Tc 99m sestamibi is used because it can be tracked during imaging to show how well blood reaches heart muscle at the time of the scan. That information helps interpret results for:
- whether tissue is receiving adequate perfusion
- whether defects look reversible (often tested via stress protocols) or fixed (suggesting scar)
What are the typical risks or side effects people ask about?
For most patients, the main “risk” is related to exposure to a small amount of radiation used for diagnostic imaging. Side effects are generally uncommon but can include nausea, headache, or injection-site discomfort, depending on the individual and procedure. Your clinicians typically weigh radiation exposure against the value of the diagnostic information.
How long does the test take, and what should patients expect?
Schedules vary by facility, but myocardial perfusion imaging often involves:
- preparation for a stress test (if a stress component is used)
- injection of the radiotracer
- imaging at one or more time points
Patients may be asked to follow instructions around caffeine, certain heart medications, or fasting depending on the protocol.
What if Myoview isn’t available—what alternatives exist?
If a specific brand isn’t available, facilities may use other technetium Tc 99m sestamibi products or alternative nuclear cardiology approaches, depending on what’s approved and what radionuclides are obtainable. Exact substitutions depend on local supply and the ordering physician’s protocol.
Is there patent or drug-market information for Myoview?
If you’re looking for commercial/patent history for Myoview or related technetium Tc 99m sestamibi products, DrugPatentWatch.com can be a useful place to check patent status and related filings: https://www.drugpatentwatch.com/
---
Quick clarification so I can answer exactly what you need
When you say “Myoview,” are you asking about:
1) the medicine/imaging test (what it is, how it’s done),
2) side effects and safety,
3) availability/shortages, or
4) patent/market status?
Reply with the number and (if relevant) your country, and I’ll tailor the answer.